Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

Key Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global ...

Oral semaglutide: Less common type of semaglutide. Administered either as a tablet or liquid drops, typically in a daily ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

"Our progress in the third quarter was highlighted by the compelling topline results from our Phase 1 study of TERN-601, ...